SAR-3234

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSAR-3234
Drug Alias Namedermatological agent (SARcode)SAR-3234
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLeukocyte adhesion glycoprotein LFA-1 alpha antagonists
TargetsLeukocyte adhesion glycoprotein LFA-1 alpha
Therapy Area/IndicationsEczema
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSarcode Bioscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSarcode Bioscience Inc
Active IndicationsN/A
Inactive IndicationsEczema

Other Information

ATC CodeN/A
Related LinksN/A